The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELYRIN | ORD | 00445A100 | 31,350,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
ADAGENE | ADR | 005329107 | 390,720 | 264,000 | SH | SOLE | 264,000 | 0 | 0 | |||
AKERO THERAPEUTICS | ORD | 00973Y108 | 83,374,987 | 1,785,714 | SH | SOLE | 1,785,714 | 0 | 0 | |||
ALIGNMENT HEALTHCARE | COM | 01625V104 | 350,711,607 | 60,993,323 | SH | SOLE | 60,993,323 | 0 | 0 | |||
ALKAMI | COM | 01644J108 | 306,981,520 | 18,729,806 | SH | SOLE | 18,729,806 | 0 | 0 | |||
ARCO PLATFORM LIMITED | CL A | G04553106 | 49,814,863 | 4,103,366 | SH | SOLE | 4,103,366 | 0 | 0 | |||
BLEND LABS | CL A | 09352U108 | 18,122,247 | 19,132,440 | SH | SOLE | 19,132,440 | 0 | 0 | |||
BUZZFEED | CL A | 12430A102 | 3,970,564 | 7,862,502 | SH | SOLE | 7,862,502 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS | Sponsored ADS | 152309100 | 59,930,453 | 9,681,818 | SH | SOLE | 9,681,818 | 0 | 0 | |||
CLEAR SECURE | CL A | 18467V109 | 112,632,150 | 4,861,120 | SH | SOLE | 4,861,120 | 0 | 0 | |||
DLOCAL | CL A | G29018101 | 779,981,212 | 63,906,695 | SH | SOLE | 63,906,695 | 0 | 0 | |||
DUOLINGO | CL A | 26603R106 | 82,996,967 | 580,642 | SH | SOLE | 580,642 | 0 | 0 | |||
ENGAGESMART | COM | 29283F103 | 1,723,283,699 | 90,271,540 | SH | SOLE | 90,271,540 | 0 | 0 | |||
EUROPEAN WAX CENTER | CL A | 29882P106 | 244,248,466 | 13,110,492 | SH | SOLE | 13,110,492 | 0 | 0 | |||
FUTU | SPON ADS CL A | 36118L106 | 44,172,759 | 1,111,544 | SH | SOLE | 1,111,544 | 0 | 0 | |||
GINKGO BIOWORKS | CL A | 37611X100 | 60,115,007 | 32,319,896 | SH | SOLE | 32,319,896 | 0 | 0 | |||
GROVE COLLABORATIVE | CL A | 39957D201 | 1,656,755 | 936,020 | SH | SOLE | 936,020 | 0 | 0 | |||
HIRERIGHT | COM | 433537107 | 363,162,946 | 32,109,898 | SH | SOLE | 32,109,898 | 0 | 0 | |||
HUTCHMED | Sponsored ADS | 44842L103 | 48,000,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | |||
IMMUNOCORE | ADS | 45258D105 | 56,962,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | |||
KARUNA THERAPEUTICS | COM | 48576A100 | 157,640,842 | 726,958 | SH | SOLE | 726,958 | 0 | 0 | |||
MOBILEYE | CL A | 60741F104 | 182,952,390 | 4,761,905 | SH | SOLE | 4,761,905 | 0 | 0 | |||
OPENDOOR | COM | 683712103 | 25,412,506 | 6,321,519 | SH | SOLE | 6,321,519 | 0 | 0 | |||
PHARVARIS | COM | N69605108 | 66,710,655 | 4,406,252 | SH | SOLE | 4,406,252 | 0 | 0 | |||
RISKIFIED | CL A | M8216R109 | 25,879,490 | 5,324,998 | SH | SOLE | 5,324,998 | 0 | 0 | |||
ROYALTY PHARMA | SHS CLASS A | G7709Q104 | 46,110,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
SQUARESPACE | CL A | 85225A107 | 705,268,242 | 22,361,073 | SH | SOLE | 22,361,073 | 0 | 0 | |||
THIRD HARMONIC BIO | COM | 88427A107 | 14,231,645 | 2,958,762 | SH | SOLE | 2,958,762 | 0 | 0 | |||
WISH | CL A | 21077C305 | 4,011,267 | 609,615 | SH | SOLE | 609,615 | 0 | 0 | |||
XP, INC | CL A | G98239109 | 694,832,016 | 29,617,733 | SH | SOLE | 29,617,733 | 0 | 0 |